InsidersTradesSigma
Follow the Semnur Pharmaceuticals, Inc. share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €191.1m. The latest transaction was disclosed on 25 September 2025 (Cession). Among the most active insiders: Scilex Holding Co. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Semnur Pharmaceuticals, Inc. is a company focused on developing treatments for pain and neurological disorders. It is listed on NASDAQ under the ticker XNAS.